Novartis
PROS Rare Disease Business Leader – CA/NV
$168K–$312K
Field Non-Sales (USA) +2 · Full-time · Posted Oct 23, 2026
- Location
- Field Non-Sales (USA)
Los Angeles (California)
San Francisco (California) - Experience
- 7+ years in specified industries, including 3+ years in one or a combination of listed commercial functions; 3+ years managing complex accounts.
- Education
- Bachelor’s degree required from 4-year college or university.
- Visa sponsorship
- Company will not sponsor visas for this position.
About the job
Leads commercial account strategy and customer engagement to improve awareness and appropriate use of a product for PROS across Centers of Excellence and other assigned accounts in California and Nevada.
What you'll do
- Develop and execute strategic account business plans and drive compliant product demand among healthcare professionals.
- Support educational programs that promote PROS awareness, patient identification, and care; collaborate with cross-functional teams and account personnel.
- Build stakeholder relationships, identify patient and account opportunities, and use digital engagement and customer insights to guide territory growth.
What they ask for
- Bachelor’s degree from a 4-year college or university.
- 7+ years’ experience in pharmaceutical, biotech, healthcare, or similarly structured industries; including 3+ years in one or a combination of Key Account/Sales, Management, Marketing, Reimbursement Management, or Institutional sales.
- 3+ years’ experience managing complex accounts, including large academic centers and hospitals, with demonstrated success in strategic account management.
- Must reside in the assigned or immediately adjacent territory within reasonable proximity to a major commercial airport; able to travel 60–80% and hold a fully valid and unrestricted driver’s license.
Nice to have
- Prior experience engaging with assigned accounts and building strong, collaborative relationships.
Pay
$168,000 and $312,000 per year (base salary)
Model-written summary · the original posting is authoritative